John Macmahon News Today

Martin McLoone, who has died at 73, was a pioneering influence in media and film studies. Born in Derry on July 12, 1950, he attended St Columb’s, the Catholic boys’ grammar school there, before studying English and history at University College Dublin, where he graduated in 1973.

The CIO and co-founder of Hawksmoor subsidiary Gore Browne, Simon James, is retiring at the end of this week after 19 years at the firm.

Tippfm.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tippfm.com Daily Mail and Mail on Sunday newspapers.

November 18, 1926 –December 29, 2022

HELLO SOCIAL RELEASE ‘SMILERS’ ACROSS SYDNEY TO PROMOTE NEW PARAMOUNT PICTURES FILM ‘SMILE’

New York, 03/16/2021 / ConsumersCompanion / The Divine Locks Complex is a one-of-a-kind formula of powerful and potent herbs designed to help women who are facing problems with their hair. This formula is brought to you by the world-famous cosmetologist and celebrity stylist Kayla Rochin and the ‘Inner Beauty And You’ cosmetics brand. The ingredients of this formula have been selected by Kayla based on the many benefits they have for your hair health. This way, this formula helps you rejuve...

Camect Analytics Add to the Power of RE:SUREs Advanced Security Monitoring Center Share Article Camect, with best-in-class artificial intelligence and video analytics for security cameras, has partnered with RE:SURE’s advanced monitoring center in the UK and Northern Ireland to help improve the accuracy of security alerts. Camect’s camera hubs are providing analytics that enable RE:SURE’s control center to further reduce false alarms and focus only on those alarms that represent a real se...

Mitre Medical gears up to treat heart disease patients in US-based study of its Mitral Touch device Mitre Medical Corp CEO John MacMahon tells Proactive the privately-held group is developing a less invasive and safer approach to treat functional mitral valve regurgitation (MR) in patients with moderate to severe MR. MacMahon says the group recently announced one-year results of the groups Mitral Touch in European patients, and looks forward to bringing the technology to the US within four diff...